Gain Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Gain Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
  • Gain Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $8K, unchanged year-over-year.
  • Gain Therapeutics, Inc. annual Depreciation for 2023 was $34.9K, a 31% increase from 2022.
  • Gain Therapeutics, Inc. annual Depreciation for 2022 was $26.6K, a 72% increase from 2021.
  • Gain Therapeutics, Inc. annual Depreciation for 2021 was $15.5K, a 61.4% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $8K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q2 2023 $17.1K +$5.64K +49% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $8K +$2.7K +50.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q2 2022 $11.5K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $5.3K +$1.9K +55.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $3.4K +$1.3K +62% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $2.1K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.